The MA for generic medicines is based on the same method of evaluation as applied to all medicines by the National Agency for the Safety of Medicines and Health Products (ANSM). All data to assess and guarantee their quality, effectiveness and safety of use must be provided by the pharmaceutical company in order to bitcoin online pharmacy generic medication the marketing authorization. After it is placed on the market, the drug continues to be monitored. The marketing authorization (MA) of a medicinal product may be suspended, in particular where a medicinal product may be harmful, it lacks the qualitative and quantitative composition declared, its labeling or package leaflet is not that it has no therapeutic effect or that its benefit / risk ratio has become unfavorable.